0001140361-20-014238.txt : 20200618
0001140361-20-014238.hdr.sgml : 20200618
20200618213840
ACCESSION NUMBER: 0001140361-20-014238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200616
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bjork Elisabeth
CENTRAL INDEX KEY: 0001810406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 20974108
MAIL ADDRESS:
STREET 1: C/O ROCKET PHARMACEUTICALS, INC.
STREET 2: 350 FIFTH AVENUE, SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
form4.xml
FORM 4
X0306
4
2020-06-16
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001810406
Bjork Elisabeth
C/O ROCKET PHARMACEUTICALS, INC.
350 FIFTH AVENUE, SUITE 7530
NEW YORK
NY
10118
true
Stock Option (Right to Buy)
19.9
2020-06-16
4
A
0
20000
0
A
2030-06-16
Common Stock
20000
20000
D
This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021
/s/ Sara Turken, as attorney-in-fact
2020-06-18